The Nausea Medicine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for nausea medicine has been experiencing a significant increase over the recent years. The market size, which was $3.02 billion in 2024, is projected to reach $3.25 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.5
The Nausea Medicine Global Market is projected to reach $4.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Nausea Medicine Market Report and Uncover Key Trends Now!The key drivers in the nausea medicine market are:
• Rising penetration of cancer treatment
• Regulatory push for safer ingredients in medicines
• Expansion of telehealth & e-prescriptions services
• Growth in minimally invasive surgeries and hospital infrastructure
The nausea medicine market covered in this report is segmented –
1) By Type: Antagonists, Antagonists, Canabinoids, Other Types
2) By Indication: Oncology, Gastroesophageal Reflux Disease, Motion Sickness and Seasickness, Other Indications
3) By Route of Administration: Oral, Injectable, Transdermal, Rectal, Other Route of Administrations
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare settings, Ambulatory Surgical centres, Long-term Care Facilities, Individual Consumers
The key trends in the nausea medicine market are:
• The integration of digital health solutions is emerging as a key trend.
• The development of targeted therapies is shaping the future of the market.
• The shift towards personalized medicine is an important upcoming trend.
• The adoption of transdermal patches for treatment and advancements in drug formulations are significantly influencing the market.
Major players in the nausea medicine market are:
• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Bayer Aktiengesellschaft
• Merck & Co. Inc.
• Sanofi S.A.
• Novartis AG
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Helsinn Healthcare SA
• Mylan N.V.
• Viatris Inc.
• Baxter International Inc.
• Teva Pharmaceutical Industries Limited
• Sun Pharmaceutical Industries Limited
• Zydus Lifesciences Limited
• Amneal Pharmaceuticals Inc.
North America was the largest region in the nausea medicine market in 2024